Florian Brand - 13 Sep 2023 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Co-Founder & Chief Executive Officer
Signature: /s/ Ryan Barrett, Attorney-in-fact
Issuer symbol: ATAI
Transactions as of: 13 Sep 2023
Net transactions value: +$57,968
Form type: 4
Filing time: 14 Sep 2023, 16:30:13 UTC
Previous filing: 30 Mar 2023
Next filing: 20 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Purchase	$57,968	+40,000	+57%	$1.45	110,000	13 Sep 2023	Direct	F1
holding	ATAI	Common Shares						2,333	13 Sep 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Remarks:

Co-Founder & Chief Executive Officer